Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods
Sutanaya Pal1★, Ekta Franscina Pinto2, Nitin B. Raut3, Girish Banwari4, Chittaranjan Andrade4★ Corresponding author
- 1Department of Psychiatry, Medical College Baroda, Vadodara, Gujarat, India.
- 2Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
- 3Department of Psychiatry, Dr. B R Ambedkar Central Railways Hospital, Byculla, Mumbai, Maharashtra, India.
- 4Neuron Psychological Care Center, Abu Dhabi, UAE.
CORRESPONDENCE
Sutanaya Pal
Department of Psychiatry, Medical College Baroda, Vadodara, Gujarat, India.
Received: 07-01-2016; Accepted: 03-03-2016.
Volume 7, Issue 3 · pp. 152–152 · PUBLISHED 2016 · DOI: 10.4103/0976-500X.189688
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Pal, S., Pinto, E. F., Raut, N. B., Banwari, G., & Andrade, C. (2016). Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods. Journal of Pharmacology and Pharmacotherapeutics, 7(3), 152–152. https://doi.org/10.4103/0976-500X.189688
